CUV.AX

Clinuvel Pharmaceuticals Limited CUV.AX

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode CUV.AX PYC.AX IMM.AX HLS.AX EBR.AX RAC.AX ACL.AX BOT.AX OCC.AX OCA.AX
6M 9.72 % 14.15 % 36.44 % -41.70 % 1.10 % 338.95 % -16.17 % -62.34 % -1.47 % 8.93 %
YTD -2.09 % -3.97 % -13.52 % -43.79 % 25.00 % 204.38 % -26.46 % -67.78 % -7.59 % 1.67 %
1Y -16.80 % -38.89 % 0.66 % -56.03 % 28.50 % 172.55 % -32.03 % -59.15 % 88.73 % -16.44 %
3Y -32.91 % 87.94 % 7.83 % -74.11 % 147.75 % 61.63 % -25.59 % 116.42 % 243.59 % -24.22 %
5Y -48.14 % -30.06 % 34.24 % -75.41 % 34.80 % 317.00 % -26.46 % 45.00 % 257.33 % -53.08 %
10Y 319.29 % 782.25 % -42.91 % -77.58 % 34.80 % 1 473.58 % -26.46 % 443.76 % 109.38 % -17.57 %
From the beginning 283.66 % -42.65 % -79.26 % -12.36 % 34.80 % 1 473.58 % -26.46 % -99.88 % 235.00 % -17.57 %

Dividend

Clinuvel Pharmaceuticals Limited

Healius Limited

Australian Clinical Labs Limited

Botanix Pharmaceuticals Limited

Oceania Healthcare Limited